Evidence map›Paper›PMID 42331336›Full record

ArticleThe plant pathology journal2026

Shifting Populations and Increasing Diversity of Colletotrichum Species Causing Pepper Anthracnose Under Rising Temperatures and Fungicide Selection Pressure.

Sohyeon An, Heung Tae Kim

Abstract read
In one paragraph

Article in The plant pathology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Sohyeon AnDepartment of Plant Medicine, Chungbuk National University, Cheongju 28644, Korea.
Heung Tae KimDepartment of Plant Medicine, Chungbuk National University, Cheongju 28644, Korea. htkim@cbnu.ac.kr.

Funding

Cooperative Research Program for Agriculture Science and Technology Development RS-2024-00398990
6 · The paper itself

Abstract

Pepper anthracnose, a devastating and economically important disease in Korea, is caused by diverse Colletotrichum species that differ significantly in their pathogenicity and environmental adaptation. In a three-year study from 2022 to 2024, pathogens were isolated and species characteristics were investigated. Using multilocus phylogenetic analysis and species-specific PCR, seven species were identified: C. scovillei, C. nymphaeae, and C. fioriniae in the C. acutatum species complex; C. fructicola, C. aenigma, and C. gloeosporioides in the C. gloeosporioides species complex; and C. truncatum. C. scovillei remained dominant, but species diversity increased in 2024, with non-dominant species such as C. fructicola and C. truncatum increasing in specific regions. Temperature-dependent assays revealed distinct ecological niches, showing that while C. scovillei prefers a moderate 25°C, high temperature-adapted species like C. fructicola and C. truncatum exhibit enhanced growth and pathogenicity at 30°C. Fungicide sensitivity tests showed that tebuconazole and fluazinam remained effective against all species of Colletotrichum, whereas pyraclostrobin (QoI) resistance was widespread. The mycelial growth inhibition of C. scovillei by pyraclostrobin ranged from 29.5% to 43.3% during 2022-2024, indicating reduced sensitivity. All C. truncatum isolates were resistant, consistently associated with the G143A mutation in the cytb gene. These findings indicate that climate warming and fungicide selection pressure are driving shifts toward more resilient populations, highlighting the need for climate-adaptive disease management through monitoring and fungicide rotation.

Indexed as

Colletotrichum spp.fungicide resistancehightemperature adaptationpepper anthracnose

Identifiers

PMID42331336
PMCPMC13462764

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.